Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects With Chronic HCV Infection

NCT02346721 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02346721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02346721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects With Chronic HCV Infection
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Completed
Start date
February 23, 2015
Completion date
June 15, 2016
Enrollment
111 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection